2024 Q3 Form 10-Q Financial Statement

#000160402824000032 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $782.6M $815.3M
YoY Change 0.31% 4.79%
Cost Of Revenue $488.7M $482.9M
YoY Change 2.34% 8.13%
Gross Profit $293.9M $332.5M
YoY Change -2.89% 0.3%
Gross Profit Margin 37.56% 40.78%
Selling, General & Admin $94.13M $94.05M
YoY Change 2.65% 8.72%
% of Gross Profit 32.02% 28.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.81M $41.10M
YoY Change 21.76% 10.36%
% of Gross Profit 15.24% 12.36%
Operating Expenses $105.9M $105.9M
YoY Change 1.29% 6.68%
Operating Profit $187.4M $226.2M
YoY Change -5.38% -2.56%
Interest Expense -$23.16M -$22.82M
YoY Change 5.54% 25.66%
% of Operating Profit -12.36% -10.09%
Other Income/Expense, Net $6.956M $7.116M
YoY Change -7.33% 100.51%
Pretax Income $171.2M $210.5M
YoY Change -6.77% -7.38%
Income Tax $40.92M $49.89M
% Of Pretax Income 23.91% 23.7%
Net Earnings $130.4M $161.4M
YoY Change -3.99% -7.05%
Net Earnings / Revenue 16.66% 19.8%
Basic Earnings Per Share $1.68 $2.08
Diluted Earnings Per Share $1.67 $2.06
COMMON SHARES
Basic Shares Outstanding 77.52M shares 77.43M shares
Diluted Shares Outstanding 78.11M shares 78.28M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $613.0M $541.6M
YoY Change 30.32% 47.95%
Cash & Equivalents $613.0M $541.6M
Short-Term Investments
Other Short-Term Assets $34.03M $25.57M
YoY Change 42.66% 0.49%
Inventory $487.2M $487.8M
Prepaid Expenses
Receivables $357.6M $369.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.492B $1.424B
YoY Change 21.11% 21.89%
LONG-TERM ASSETS
Property, Plant & Equipment $955.4M $927.7M
YoY Change 23.44% 24.13%
Goodwill $617.1M $617.0M
YoY Change -0.49% -0.54%
Intangibles $328.9M $340.7M
YoY Change -13.91% -13.7%
Long-Term Investments
YoY Change
Other Assets $142.3M $137.8M
YoY Change 9.61% 17.19%
Total Long-Term Assets $2.044B $2.023B
YoY Change 7.23% 7.61%
TOTAL ASSETS
Total Short-Term Assets $1.492B $1.424B
Total Long-Term Assets $2.044B $2.023B
Total Assets $3.536B $3.448B
YoY Change 12.68% 13.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $273.3M $264.8M
YoY Change 22.26% 28.81%
Accrued Expenses $152.1M $148.3M
YoY Change -4.22% 7.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $11.13M $11.49M
YoY Change -14.05% -52.64%
Total Short-Term Liabilities $467.3M $492.9M
YoY Change 9.22% 17.48%
LONG-TERM LIABILITIES
Long-Term Debt $1.255B $1.257B
YoY Change -0.72% -2.95%
Other Long-Term Liabilities $76.18M $77.19M
YoY Change 4.44% 23.15%
Total Long-Term Liabilities $1.331B $1.335B
YoY Change -0.44% -1.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $467.3M $492.9M
Total Long-Term Liabilities $1.331B $1.335B
Total Liabilities $2.043B $2.063B
YoY Change 4.48% 5.48%
SHAREHOLDERS EQUITY
Retained Earnings $1.359B $1.241B
YoY Change 48.77% 57.35%
Common Stock $1.267B $1.253B
YoY Change 6.94% 8.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.376B $1.263B
YoY Change
Total Liabilities & Shareholders Equity $3.536B $3.448B
YoY Change 12.68% 13.08%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $130.4M $161.4M
YoY Change -3.99% -7.05%
Depreciation, Depletion And Amortization $44.81M $41.10M
YoY Change 21.76% 10.36%
Cash From Operating Activities $166.9M $183.4M
YoY Change -22.34% -24.82%
INVESTING ACTIVITIES
Capital Expenditures $54.47M $57.72M
YoY Change 34.33% 37.16%
Acquisitions
YoY Change
Other Investing Activities $142.0K -$498.0K
YoY Change -52.67% -102.47%
Cash From Investing Activities -$54.33M -$57.22M
YoY Change 34.8% 160.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.75M -$73.90M
YoY Change -41.71% 0.52%
NET CHANGE
Cash From Operating Activities 166.9M $183.4M
Cash From Investing Activities -54.33M -$57.22M
Cash From Financing Activities -40.75M -$73.90M
Net Change In Cash 71.83M $51.52M
YoY Change -31.39% -65.31%
FREE CASH FLOW
Cash From Operating Activities $166.9M $183.4M
Capital Expenditures $54.47M $57.72M
Free Cash Flow $112.4M $125.7M
YoY Change -35.51% -37.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 wms Cost Of Goods Sold Excluding Employee Stock Option Plan Special Dividend Compensation
CostOfGoodsSoldExcludingEmployeeStockOptionPlanSpecialDividendCompensation
482882000 usd
CY2023Q2 wms Cost Of Goods Sold Excluding Employee Stock Option Plan Special Dividend Compensation
CostOfGoodsSoldExcludingEmployeeStockOptionPlanSpecialDividendCompensation
446586000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
86511000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-292000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1701000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1675000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
162322000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
173905000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
920000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
253000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
161402000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
173652000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77540000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78908000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78282000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79634000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.08
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
CY2024Q2 us-gaap Profit Loss
ProfitLoss
162322000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
173905000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3749000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3232000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
158573000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
177137000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-1788000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
1051000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
920000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
253000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
159441000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
175833000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41098000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37240000 usd
CY2024Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-942000 usd
CY2023Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
573000 usd
CY2024Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-292000 usd
CY2023Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
13304000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6977000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6903000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1701000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1675000 usd
CY2024Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3754000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-501000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30860000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3726000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3699000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
54320000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
45594000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
183426000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
243967000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57715000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42078000 usd
CY2024Q2 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2023Q2 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
19979000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
332454000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
331460000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
94052000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
13304000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11895000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12802000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
226215000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
245451000 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-22824000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-21712000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7116000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3549000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
210507000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
227288000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49886000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55058000 usd
CY2024Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
511000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
511000 usd
CY2024Q2 wms Unrealized Gain Loss On Derivatives And Commodity Contracts Excluding Foreign Exchange Forward Contracts
UnrealizedGainLossOnDerivativesAndCommodityContractsExcludingForeignExchangeForwardContracts
-45000 usd
CY2023Q2 wms Unrealized Gain Loss On Derivatives And Commodity Contracts Excluding Foreign Exchange Forward Contracts
UnrealizedGainLossOnDerivativesAndCommodityContractsExcludingForeignExchangeForwardContracts
36000 usd
CY2024Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
46991000 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
33406000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25025000 usd
CY2024Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-498000 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-155000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57217000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21944000 usd
CY2024Q2 wms Repayments Of Syndicated Term Loan Facility
RepaymentsOfSyndicatedTermLoanFacility
1750000 usd
CY2023Q2 wms Repayments Of Syndicated Term Loan Facility
RepaymentsOfSyndicatedTermLoanFacility
1750000 usd
CY2024Q2 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1342000 usd
CY2023Q2 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
2256000 usd
CY2024Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5513000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2769000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
49245000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
47778000 usd
CY2024Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12428000 usd
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11084000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6978000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
867000 usd
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10558000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8742000 usd
CY2024Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-37000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73895000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73512000 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-792000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
465000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
51522000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
148976000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
495848000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217128000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
547370000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366104000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
541637000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5733000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
547370000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
841640000 usd
CY2023Q2 wms Profit Loss Excluding Portion Attributable To Redeemable Noncontrolling Interest
ProfitLossExcludingPortionAttributableToRedeemableNoncontrollingInterest
173905000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3232000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
11087000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
48071000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4823000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
867000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2345000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-6394000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6903000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-4000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
963469000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1172115000 usd
CY2024Q2 wms Profit Loss Excluding Portion Attributable To Redeemable Noncontrolling Interest
ProfitLossExcludingPortionAttributableToRedeemableNoncontrollingInterest
162322000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3749000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
12449000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
48333000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4818000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6978000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4620000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-5936000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6977000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2964000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-40000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1281047000 usd
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1713000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1353000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5236000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3920000 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
110874000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106662000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
376959000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
357538000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
487833000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
464200000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
161402000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
173652000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77540000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78908000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.08
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
161402000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
173652000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77540000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78908000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78282000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79634000 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1278054000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1281151000 usd
CY2024Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
9248000 usd
CY2024Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
9759000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
11486000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
11870000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1257320000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1259522000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6977000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6903000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6977000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6903000 usd
CY2024Q2 us-gaap Share Price
SharePrice
177.38
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.455
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.045
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0036
CY2024Q2 wms Employee Stock Purchase Plan Maximum Shares In Offering Period
EmployeeStockPurchasePlanMaximumSharesInOfferingPeriod
400000 shares
CY2024Q2 wms Employee Stock Purchase Plan Purchase Discount
EmployeeStockPurchasePlanPurchaseDiscount
0.85 rate
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
815336000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
815336000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
778046000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
778046000 usd
CY2024Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
361007000 usd
CY2023Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
355072000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41098000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37240000 usd
CY2024Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
57715000 usd
CY2023Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
42078000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
332454000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
331460000 usd
CY2024Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
361007000 usd
CY2023Q2 wms Adjusted Gross Profit
AdjustedGrossProfit
355072000 usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
839000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1553000 usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
10019000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
8499000 usd
CY2024Q2 wms Stock Repurchase Costs Incurred But Not Yet Paid
StockRepurchaseCostsIncurredButNotYetPaid
810000 usd
CY2023Q2 wms Stock Repurchase Costs Incurred But Not Yet Paid
StockRepurchaseCostsIncurredButNotYetPaid
0 usd
CY2024Q2 wms Excise Tax Accrual Share Repurchase
ExciseTaxAccrualShareRepurchase
0 usd
CY2023Q2 wms Excise Tax Accrual Share Repurchase
ExciseTaxAccrualShareRepurchase
293000 usd
CY2024Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
27896000 usd
CY2023Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
944000 usd
CY2024Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
32885000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19781000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
162322000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
173905000 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-22824000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-21712000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49886000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55058000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-292000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
13304000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
wms-20240630_cal.xml Edgar Link unprocessable
0001604028-24-000032-index-headers.html Edgar Link pending
0001604028-24-000032-index.html Edgar Link pending
0001604028-24-000032.txt Edgar Link pending
0001604028-24-000032-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wms-06302024xexhibit311.htm Edgar Link pending
wms-06302024xexhibit312.htm Edgar Link pending
wms-06302024xexhibit321.htm Edgar Link pending
wms-06302024xexhibit322.htm Edgar Link pending
wms-20240630.htm Edgar Link pending
wms-20240630.xsd Edgar Link pending
wms-20240630_def.xml Edgar Link unprocessable
wms-20240630_lab.xml Edgar Link unprocessable
wms-20240630_pre.xml Edgar Link unprocessable
wms-20240630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable